Inhibition of c-MYC-miRNA 19 Pathway Sensitized CML K562 Cells to Etoposide via NHE1 Upregulation.
Shannan CaoQingqing XiongBowen DingXu WangFeng WeiQian SunFan YangJing LuoGuoqiang ChangSuxin LiJian WangPublished in: Oxidative medicine and cellular longevity (2022)
As a previously discovered target of DNA damage, Na + /H + exchanger 1 (NHE1) plays a role in regulation of intracellular pH (pH i ) through the extrusion of intracellular proton (H + ) in exchange for extracellular sodium (Na + ). Its abnormal expression and dysfunction have been reported in solid tumor and hematopoietic malignancies. Here, we reported that suppression of NHE1 in BCR-ABL + hematopoietic malignancies' K562 cells treated with Etoposide was manipulated by miR-19 and c-MYC. Inhibition of miR-19 or c-MYC enhanced the expression of NHE1 and sensitized K562 cells to Etoposide in vitro . The in vivo nude mouse transplantation model was also performed to confirm the enhanced sensitivity of K562 cells to Etoposide by inhibiting the miR-19 or c-MYC pathway. TCGA analysis conferred a negative correlation between miR-19 level and leukemia patients' survival. Thus, our results provided a potential management by which the c-MYC-miRNA 19 pathway might have a crucial impact on sensitizing K562 cells to Etoposide in the therapeutic approaches.
Keyphrases
- induced apoptosis
- cell proliferation
- cell cycle arrest
- long non coding rna
- dna damage
- poor prognosis
- oxidative stress
- end stage renal disease
- long noncoding rna
- signaling pathway
- chronic kidney disease
- bone marrow
- stem cells
- newly diagnosed
- acute myeloid leukemia
- cell death
- ejection fraction
- acute lymphoblastic leukemia
- risk assessment
- binding protein